Cepheid

Cepheid Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility.

Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing "A Better Way" for institutions of any size to perform world-class PCR testing. Cepheid

’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology, and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit http://www.cepheid.com. Cepheid is proud to be a part of Danaher. Danaher’s science and technology leadership puts Cepheid’s solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics, and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.

Today, on World Leukemia Day, we stand with patients, families, caregivers, advocates, andhealthcare professionals aroun...
09/04/2026

Today, on World Leukemia Day, we stand with patients, families, caregivers, advocates, and
healthcare professionals around the world affected by leukemia. Raising awareness is an important step toward earlier diagnosis, greater access to care, and improved outcomes.

Together, we can help shine a light on the challenges faced by those living with blood cancers and support ongoing efforts to advance patient care.

More than 1 million curable sexually transmitted infections are acquired worldwide everyday.* This World Sexual Health D...
09/04/2026

More than 1 million curable sexually transmitted infections are acquired worldwide every
day.* This World Sexual Health Day, learn how Cepheid’s Blood Virology, Women’s Health,
and Sexual Health testing solutions help support informed clinical decision-making through molecular diagnostics.

*WHO:
https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis)

IVD. In Vitro Diagnostic Medical Device. May not be available in all countries

📢 We're proud to announce that the World Health Organization (WHO) has granted Emergency Use Listing (EUL) for Cepheid's...
09/03/2026

📢 We're proud to announce that the World Health Organization (WHO) has granted Emergency Use Listing (EUL) for Cepheid's Xpert® Hemorrhagic Fever Panel, supporting efforts to respond to the Ebola outbreak in the Democratic Republic of the Congo. Read more:

https://ow.ly/fV8Y50ZITFU

What happens when GBS status is unknown at the time of labour?For clinicians, every decision matters. Access to timely d...
09/03/2026

What happens when GBS status is unknown at the time of labour?

For clinicians, every decision matters. Access to timely diagnostic information can help support informed treatment choices and optimize care for both mothers and newborns.
Join our live expert panel discussion to hear firsthand experiences from experts who are implementing and evaluating intrapartum GBS testing in clinical practice.

You'll gain insights into:

🔹 The limitations of traditional screening approaches
🔹 The value of rapid intrapartum testing
🔹 Lessons learned from implementation in Europe
🔹 Perspectives from microbiology, obstetrics, gynaecology, and patients

This interactive discussion will offer valuable insights for microbiology laboratories, maternity services, obstetricians, and healthcare professionals interested in improving GBS management pathways.

👉 Reserve your seat today and register now:
https://ow.ly/XS1650ZHtGx

💡Last week, teams from Cepheid and the Fleming Initiative came together to align on a comprehensive roadmap for clinical...
09/02/2026

💡Last week, teams from Cepheid and the Fleming Initiative came together to align on a comprehensive roadmap for clinical evidence generation, real-world data, and communications efforts that will support our shared commitment to addressing antimicrobial resistance (AMR) and diagnostic excellence.

🔬In this photo, Anne Beauburn stands outside the Alexander Fleming Laboratory Museum in London, where Alexander Fleming discovered penicillin in 1928. The historic site serves as a powerful reminder of both the transformative impact of antibiotics and the urgent responsibility we share to preserve their effectiveness.

🧑‍🔬Through this collaboration, Cepheid and the Fleming Initiative aim to strengthen the evidence base needed to advance diagnostic excellence, support informed clinical decision-making, and improve outcomes for patients around the world.

We look forward to the important work ahead and the impact we can achieve together.

#

🦠Flu? Covid? RSV? Winter brings a surge in respiratory infections, and when symptoms overlap, clarity matters. With fast...
09/01/2026

🦠Flu? Covid? RSV? Winter brings a surge in respiratory infections, and when symptoms overlap, clarity matters. With fast and accurate PCR testing on the GeneXpert® system, healthcare teams can make quick decisions, optimize patient flow, and preserve hospital resources when it matters most.

Be prepared for winter with Cepheid’s Winter Care Bundle: https://ow.ly/jW8Q50ZxMhq

Congratulations to the recent winners of the 2026 President's Kaizen Sustainment Award: the Finished Goods Release Lead-...
08/31/2026

Congratulations to the recent winners of the 2026 President's Kaizen Sustainment Award: the Finished Goods Release Lead-Time Reduction Team led by Sotirios Papakosta and facilitators Vijay Singh and Chris Erbin. The winners demonstrated outstanding teamwork, ownership, and ex*****on, earning both the Kaizen Week Winner and Sustainment Winner recognition.

👏 Congratulations to the entire team!

In fast-paced outpatient settings, every diagnostic result should help advance care. Rhinovirus is a common inclusion on...
08/28/2026

In fast-paced outpatient settings, every diagnostic result should help advance care. Rhinovirus is a common inclusion on low-plex respiratory panels, but how often does it truly impact what you do next?

Before testing for rhinovirus in an outpatient setting, it’s worth asking:

✅ Does the test distinguish between rhinovirus and enterovirus?
✅ Will this result change patient management today?
✅ Could co-circulating pathogens be missed?

Our latest Insight Hub article breaks down the nuances and offers a practical lens for aligning test selection with real-world clinical decision-making.

👉 Read the full article:
https://ow.ly/VnBn50ZFpvX

08/26/2026

A recent "Atlantic" article highlights the urgent need for expanded Ebola testing in the Democratic Republic of the Congo.

“The fastest solution to Congo’s testing crisis would be to distribute GeneXpert cartridges that can detect Bundibugyo. After all, hundreds of hospitals already have the machines, and each can run 80 or so patient samples at once, which would allow many patients to get same-day results,” notes Christian Happi, a molecular biologist who leads a team in Congo working on surveilling this outbreak.

Access the story here:
https://www.theatlantic.com/health/2026/08/ebola-testing/688215/

💻 Live Webinar: Navigating Vaginitis Testing Reimbursement. Stay up to date on the latest reimbursement developments for...
08/25/2026

💻 Live Webinar: Navigating Vaginitis Testing Reimbursement. Stay up to date on the latest reimbursement developments for molecular vaginitis testing. Learn about Xpert® Xpress MVP, the transition to CPT® 81515, current payer coverage trends, and available support resources to help optimize patient access.

✅ Results in ~60 minutes at the point of care
✅ Broad payer coverage insights
✅ Reimbursement best practices and support

Register today!
https://event.on24.com/wcc/r/5461150/5B4206766F4D4701B699EE5880D9A6E6

Address

904 E Caribbean Drive
Sunnyvale, CA
94089

Alerts

Be the first to know and let us send you an email when Cepheid posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share